VR Logo

Takeda Pharmaceutical Company Limited (TAK) download report


Healthcare | Drugs & Pharma

Takeda Pharmaceutical Company Limited (TAK) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide.

IPO Date: 27-Oct-2008

Pres, CEO & Representative Director: Mr. Christophe Weber

CFO & Representative Director: Mr. Constantine Saroukos

Listing: NYSE: TAK

Country: Japan

Headquarters: Tokyo,

Website: https://www.takeda.com

Key Facts

Market cap: $42,978.74 Mln

Revenue (TTM): JP¥3,569,006.00 Mln

Earnings (TTM): JP¥230,059.00 Mln

Cash: JP¥875,000.00 Mln

Total Debt: JP¥4,345,411.00 Mln

Insider's Holding: 0.01%

Liquidity: Low

52 Week range: $13.05 - 17.31

Shares outstanding: 3,105,400,064

10 Years Aggregate:

  • CFO: JP¥4,435,536.00 Mln
  • EBITDA: JP¥4,947,477.00 Mln
  • Net Profit: JP¥1,233,550.00 Mln

Stock Performance

Time Period Takeda Pharmaceutical Company Limited (TAK) S&P 100 S&P BSE Healthcare
YTD3.37-18.56-17.10
1 month-5.05-2.50-2.03
3 months-5.63-14.54-10.73
1 Year-16.77-8.46-13.45
3 Years-6.5811.5219.07
5 Years-9.7310.709.15
10 Years-1.6711.4412.44
As on 27-Jun-2022
Year Takeda Pharmaceutical Company Limited (TAK) S&P 100 S&P BSE Healthcare
2021-25.1127.5520.87
2020-7.7519.3061.45
201917.3029.47-3.55
2018-40.71-5.82-5.89
201736.9119.340.49
2016-16.988.78-12.88
201520.680.3415.06